Tumor Biomarker Test Market Report

Global Tumor Biomarker Test Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Mar 26, 2021
  • PAGES：188
  • REPORT CODE：GMM637846
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Tumor Biomarker Test is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Tumor Biomarker Test market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Tumor Biomarker Test industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Tumor Biomarker Test Market Segmentations:

    By Players:

    • Becton Dickinson and Co

    • Abbott Laboratories, Inc

    • NanoString Technologies Inc

    • Illumina Inc

    • AstraZeneca

    • Danaher Corporation

    • Biocept Inc

    • Cancer Genetics Inc

    • Agilent Technologies

    • Myriad Genetics Inc

    • LabCorp Of America Holdings

    • Foundation Medicine Inc

    • Luminex Corporation

    By Types:

    • Prostate Specific Antigen Tests

    • CTC Tests

    • Alpha-Fetoprotein (AFP) Tests

    • CA Test

    • HER2 Tests

    • BRCA Test

    • Anaplastic Lymphoma Kinase (ALK) Tests

    • EGFR Mutation Tests

    • KRAS Test

    • Others

    By End-User:

    • Lung Cancer

    • Breast Cancer

    • Colorectal

    • Prostate Cancer

    • Blood Cancer

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Tumor Biomarker Test Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Tumor Biomarker Test Market Size and Growth Rate of Prostate Specific Antigen Tests from 2014 to 2026

      • 1.3.2 Global Tumor Biomarker Test Market Size and Growth Rate of CTC Tests from 2014 to 2026

      • 1.3.3 Global Tumor Biomarker Test Market Size and Growth Rate of Alpha-Fetoprotein (AFP) Tests from 2014 to 2026

      • 1.3.4 Global Tumor Biomarker Test Market Size and Growth Rate of CA Test from 2014 to 2026

      • 1.3.5 Global Tumor Biomarker Test Market Size and Growth Rate of HER2 Tests from 2014 to 2026

      • 1.3.6 Global Tumor Biomarker Test Market Size and Growth Rate of BRCA Test from 2014 to 2026

      • 1.3.7 Global Tumor Biomarker Test Market Size and Growth Rate of Anaplastic Lymphoma Kinase (ALK) Tests from 2014 to 2026

      • 1.3.8 Global Tumor Biomarker Test Market Size and Growth Rate of EGFR Mutation Tests from 2014 to 2026

      • 1.3.9 Global Tumor Biomarker Test Market Size and Growth Rate of KRAS Test from 2014 to 2026

      • 1.3.10 Global Tumor Biomarker Test Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Tumor Biomarker Test Market Size and Growth Rate of Lung Cancer from 2014 to 2026

      • 1.4.2 Global Tumor Biomarker Test Market Size and Growth Rate of Breast Cancer from 2014 to 2026

      • 1.4.3 Global Tumor Biomarker Test Market Size and Growth Rate of Colorectal from 2014 to 2026

      • 1.4.4 Global Tumor Biomarker Test Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

      • 1.4.5 Global Tumor Biomarker Test Market Size and Growth Rate of Blood Cancer from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Tumor Biomarker Test Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Tumor Biomarker Test Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Tumor Biomarker Test by Major Types

      • 3.4.1 Tumor Biomarker Test Market Size and Growth Rate of Prostate Specific Antigen Tests

      • 3.4.2 Tumor Biomarker Test Market Size and Growth Rate of CTC Tests

      • 3.4.3 Tumor Biomarker Test Market Size and Growth Rate of Alpha-Fetoprotein (AFP) Tests

      • 3.4.4 Tumor Biomarker Test Market Size and Growth Rate of CA Test

      • 3.4.5 Tumor Biomarker Test Market Size and Growth Rate of HER2 Tests

      • 3.4.6 Tumor Biomarker Test Market Size and Growth Rate of BRCA Test

      • 3.4.7 Tumor Biomarker Test Market Size and Growth Rate of Anaplastic Lymphoma Kinase (ALK) Tests

      • 3.4.8 Tumor Biomarker Test Market Size and Growth Rate of EGFR Mutation Tests

      • 3.4.9 Tumor Biomarker Test Market Size and Growth Rate of KRAS Test

      • 3.4.10 Tumor Biomarker Test Market Size and Growth Rate of Others

    4 Segmentation of Tumor Biomarker Test Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Tumor Biomarker Test by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Tumor Biomarker Test in Lung Cancer

      • 4.4.2 Market Size and Growth Rate of Tumor Biomarker Test in Breast Cancer

      • 4.4.3 Market Size and Growth Rate of Tumor Biomarker Test in Colorectal

      • 4.4.4 Market Size and Growth Rate of Tumor Biomarker Test in Prostate Cancer

      • 4.4.5 Market Size and Growth Rate of Tumor Biomarker Test in Blood Cancer

    5 Market Analysis by Major Regions

    • 5.1 Global Tumor Biomarker Test Production Analysis by Major Regions

    • 5.2 Global Tumor Biomarker Test Consumption Analysis by Major Regions

    • 5.3 Global Tumor Biomarker Test Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Tumor Biomarker Test Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Tumor Biomarker Test Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Tumor Biomarker Test Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Tumor Biomarker Test Production, Import, Consumption and Export Analysis

    6 Product Commodity of Tumor Biomarker Test Market in Major Countries

    • 6.1 Top 5 Export Countries in Tumor Biomarker Test market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Tumor Biomarker Test market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Tumor Biomarker Test market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Tumor Biomarker Test market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Tumor Biomarker Test market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Tumor Biomarker Test market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Tumor Biomarker Test Landscape Analysis

    • 7.1 North America Tumor Biomarker Test Landscape Analysis by Major Types

    • 7.2 North America Tumor Biomarker Test Landscape Analysis by Major End-Users

    • 7.3 North America Tumor Biomarker Test Landscape Analysis by Major Countries

      • 7.3.1 United States Tumor Biomarker Test Market Volume and Growth Rate

      • 7.3.2 Canada Tumor Biomarker Test Market Volume and Growth Rate

      • 7.3.3 Mexico Tumor Biomarker Test Market Volume and Growth Rate

    8 Europe Tumor Biomarker Test Landscape Analysis

    • 8.1 Europe Tumor Biomarker Test Landscape Analysis by Major Types

    • 8.2 Europe Tumor Biomarker Test Landscape Analysis by Major End-Users

    • 8.3 Europe Tumor Biomarker Test Landscape Analysis by Major Countries

      • 8.3.1 Germany Tumor Biomarker Test Market Volume and Growth Rate

      • 8.3.2 UK Tumor Biomarker Test Market Volume and Growth Rate

      • 8.3.3 France Tumor Biomarker Test Market Volume and Growth Rate

      • 8.3.4 Italy Tumor Biomarker Test Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Tumor Biomarker Test Market Volume and Growth Rate

      • 8.3.6 Spain Tumor Biomarker Test Market Volume and Growth Rate

      • 8.3.7 Belgium Tumor Biomarker Test Market Volume and Growth Rate

      • 8.3.8 Poland Tumor Biomarker Test Market Volume and Growth Rate

      • 8.3.9 Russia Tumor Biomarker Test Market Volume and Growth Rate

      • 8.3.10 Turkey Tumor Biomarker Test Market Volume and Growth Rate

    9 Asia Pacific Tumor Biomarker Test Landscape Analysis

    • 9.1 Asia Pacific Tumor Biomarker Test Landscape Analysis by Major Types

    • 9.2 Asia Pacific Tumor Biomarker Test Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Tumor Biomarker Test Landscape Analysis by Major Countries

      • 9.3.1 China Tumor Biomarker Test Market Volume and Growth Rate

      • 9.3.2 Japan Tumor Biomarker Test Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Tumor Biomarker Test Market Volume and Growth Rate

      • 9.3.4 India Tumor Biomarker Test Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Tumor Biomarker Test Market Volume and Growth Rate

      • 9.3.6 South Korea Tumor Biomarker Test Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Tumor Biomarker Test Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Tumor Biomarker Test Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Tumor Biomarker Test Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Tumor Biomarker Test Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Tumor Biomarker Test Market Volume and Growth Rate

      • 10.3.2 Brazil Tumor Biomarker Test Market Volume and Growth Rate

      • 10.3.3 Nigeria Tumor Biomarker Test Market Volume and Growth Rate

      • 10.3.4 South Africa Tumor Biomarker Test Market Volume and Growth Rate 

      • 10.3.5 Argentina Tumor Biomarker Test Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Becton Dickinson and Co

      • 11.1.1 Becton Dickinson and Co Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Abbott Laboratories, Inc

      • 11.2.1 Abbott Laboratories, Inc Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 NanoString Technologies Inc

      • 11.3.1 NanoString Technologies Inc Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Illumina Inc

      • 11.4.1 Illumina Inc Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 AstraZeneca

      • 11.5.1 AstraZeneca Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Danaher Corporation

      • 11.6.1 Danaher Corporation Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Biocept Inc

      • 11.7.1 Biocept Inc Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Cancer Genetics Inc

      • 11.8.1 Cancer Genetics Inc Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Agilent Technologies

      • 11.9.1 Agilent Technologies Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Myriad Genetics Inc

      • 11.10.1 Myriad Genetics Inc Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 LabCorp Of America Holdings

      • 11.11.1 LabCorp Of America Holdings Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Foundation Medicine Inc

      • 11.12.1 Foundation Medicine Inc Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Luminex Corporation

      • 11.13.1 Luminex Corporation Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 96 Figures and 149 Tables)

    • Figure Product Picture

    • Figure Tumor Biomarker Test Market Size and Growth Rate of Prostate Specific Antigen Tests from 2014 to 2026

    • Figure Tumor Biomarker Test Market Size and Growth Rate of CTC Tests from 2014 to 2026

    • Figure Tumor Biomarker Test Market Size and Growth Rate of Alpha-Fetoprotein (AFP) Tests from 2014 to 2026

    • Figure Tumor Biomarker Test Market Size and Growth Rate of CA Test from 2014 to 2026

    • Figure Tumor Biomarker Test Market Size and Growth Rate of HER2 Tests from 2014 to 2026

    • Figure Tumor Biomarker Test Market Size and Growth Rate of BRCA Test from 2014 to 2026

    • Figure Tumor Biomarker Test Market Size and Growth Rate of Anaplastic Lymphoma Kinase (ALK) Tests from 2014 to 2026

    • Figure Tumor Biomarker Test Market Size and Growth Rate of EGFR Mutation Tests from 2014 to 2026

    • Figure Tumor Biomarker Test Market Size and Growth Rate of KRAS Test from 2014 to 2026

    • Figure Tumor Biomarker Test Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Lung Cancer from 2014 to 2026

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Breast Cancer from 2014 to 2026

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Colorectal from 2014 to 2026

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Blood Cancer from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Tumor Biomarker Test Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Tumor Biomarker Test Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Tumor Biomarker Test

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Tumor Biomarker Test by Different Types from 2014 to 2026

    • Table Consumption Share of Tumor Biomarker Test by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Prostate Specific Antigen Tests

    • Figure Market Size and Growth Rate of CTC Tests

    • Figure Market Size and Growth Rate of Alpha-Fetoprotein (AFP) Tests

    • Figure Market Size and Growth Rate of CA Test

    • Figure Market Size and Growth Rate of HER2 Tests

    • Figure Market Size and Growth Rate of BRCA Test

    • Figure Market Size and Growth Rate of Anaplastic Lymphoma Kinase (ALK) Tests

    • Figure Market Size and Growth Rate of EGFR Mutation Tests

    • Figure Market Size and Growth Rate of KRAS Test

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Tumor Biomarker Test by Different End-Users from 2014 to 2026

    • Table Consumption Share of Tumor Biomarker Test by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Lung Cancer

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Colorectal

    • Figure Market Size and Growth Rate of Prostate Cancer

    • Figure Market Size and Growth Rate of Blood Cancer

    • Table Global Tumor Biomarker Test Production by Major Regions

    • Table Global Tumor Biomarker Test Production Share by Major Regions

    • Figure Global Tumor Biomarker Test Production Share by Major Regions in 2014

    • Figure Global Tumor Biomarker Test Production Share by Major Regions in 2018

    • Figure Global Tumor Biomarker Test Production Share by Major Regions in 2026

    • Table Global Tumor Biomarker Test Consumption by Major Regions

    • Table Global Tumor Biomarker Test Consumption Share by Major Regions

    • Figure Global Tumor Biomarker Test Consumption Share by Major Regions in 2014

    • Figure Global Tumor Biomarker Test Consumption Share by Major Regions in 2018

    • Figure Global Tumor Biomarker Test Consumption Share by Major Regions in 2026

    • Table North America Tumor Biomarker Test Production, Import, Consumption and Export Analysis

    • Table Europe Tumor Biomarker Test Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Tumor Biomarker Test Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Tumor Biomarker Test Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Tumor Biomarker Test market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Tumor Biomarker Test market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Tumor Biomarker Test market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Tumor Biomarker Test market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Tumor Biomarker Test Consumption by Types from 2014 to 2026

    • Table North America Tumor Biomarker Test Consumption Share by Types from 2014 to 2026

    • Figure North America Tumor Biomarker Test Consumption Share by Types in 2014

    • Figure North America Tumor Biomarker Test Consumption Share by Types in 2018

    • Figure North America Tumor Biomarker Test Consumption Share by Types in 2026

    • Table North America Tumor Biomarker Test Consumption by End-Users from 2014 to 2026

    • Table North America Tumor Biomarker Test Consumption Share by End-Users from 2014 to 2026

    • Figure North America Tumor Biomarker Test Consumption Share by End-Users in 2014

    • Figure North America Tumor Biomarker Test Consumption Share by End-Users in 2018

    • Figure North America Tumor Biomarker Test Consumption Share by End-Users in 2026

    • Table North America Tumor Biomarker Test Consumption by Major Countries from 2014 to 2026

    • Table North America Tumor Biomarker Test Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Tumor Biomarker Test Consumption Share by Major Countries in 2014

    • Figure North America Tumor Biomarker Test Consumption Share by Major Countries in 2018

    • Figure North America Tumor Biomarker Test Consumption Share by Major Countries in 2026

    • Figure United States Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Tumor Biomarker Test Consumption by Types from 2014 to 2026

    • Table Europe Tumor Biomarker Test Consumption Share by Types from 2014 to 2026

    • Figure Europe Tumor Biomarker Test Consumption Share by Types in 2014

    • Figure Europe Tumor Biomarker Test Consumption Share by Types in 2018

    • Figure Europe Tumor Biomarker Test Consumption Share by Types in 2026

    • Table Europe Tumor Biomarker Test Consumption by End-Users from 2014 to 2026

    • Table Europe Tumor Biomarker Test Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Tumor Biomarker Test Consumption Share by End-Users in 2014

    • Figure Europe Tumor Biomarker Test Consumption Share by End-Users in 2018

    • Figure Europe Tumor Biomarker Test Consumption Share by End-Users in 2026

    • Table Europe Tumor Biomarker Test Consumption by Major Countries from 2014 to 2026

    • Table Europe Tumor Biomarker Test Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Tumor Biomarker Test Consumption Share by Major Countries in 2014

    • Figure Europe Tumor Biomarker Test Consumption Share by Major Countries in 2018

    • Figure Europe Tumor Biomarker Test Consumption Share by Major Countries in 2026

    • Figure Germany Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure France Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Tumor Biomarker Test Consumption by Types from 2014 to 2026

    • Table Asia Pacific Tumor Biomarker Test Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Tumor Biomarker Test Consumption Share by Types in 2014

    • Figure Asia Pacific Tumor Biomarker Test Consumption Share by Types in 2018

    • Figure Asia Pacific Tumor Biomarker Test Consumption Share by Types in 2026

    • Table Asia Pacific Tumor Biomarker Test Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Tumor Biomarker Test Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Tumor Biomarker Test Consumption Share by End-Users in 2014

    • Figure Asia Pacific Tumor Biomarker Test Consumption Share by End-Users in 2018

    • Figure Asia Pacific Tumor Biomarker Test Consumption Share by End-Users in 2026

    • Table Asia Pacific Tumor Biomarker Test Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Tumor Biomarker Test Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Tumor Biomarker Test Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Tumor Biomarker Test Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Tumor Biomarker Test Consumption Share by Major Countries in 2026

    • Figure China Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandTumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure India Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Tumor Biomarker Test Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Tumor Biomarker Test Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Tumor Biomarker Test Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Tumor Biomarker Test Consumption Share by Major Countries in 2026

    • Figure GCC Countries Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Tumor Biomarker Test Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Becton Dickinson and Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton Dickinson and Co

    • Figure Sales and Growth Rate Analysis of Becton Dickinson and Co

    • Figure Revenue and Market Share Analysis of Becton Dickinson and Co

    • Table Product and Service Introduction of Becton Dickinson and Co

    • Table Company Profile and Development Status of Abbott Laboratories, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories, Inc

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories, Inc

    • Figure Revenue and Market Share Analysis of Abbott Laboratories, Inc

    • Table Product and Service Introduction of Abbott Laboratories, Inc

    • Table Company Profile and Development Status of NanoString Technologies Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NanoString Technologies Inc

    • Figure Sales and Growth Rate Analysis of NanoString Technologies Inc

    • Figure Revenue and Market Share Analysis of NanoString Technologies Inc

    • Table Product and Service Introduction of NanoString Technologies Inc

    • Table Company Profile and Development Status of Illumina Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina Inc

    • Figure Sales and Growth Rate Analysis of Illumina Inc

    • Figure Revenue and Market Share Analysis of Illumina Inc

    • Table Product and Service Introduction of Illumina Inc

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Danaher Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Danaher Corporation

    • Figure Sales and Growth Rate Analysis of Danaher Corporation

    • Figure Revenue and Market Share Analysis of Danaher Corporation

    • Table Product and Service Introduction of Danaher Corporation

    • Table Company Profile and Development Status of Biocept Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocept Inc

    • Figure Sales and Growth Rate Analysis of Biocept Inc

    • Figure Revenue and Market Share Analysis of Biocept Inc

    • Table Product and Service Introduction of Biocept Inc

    • Table Company Profile and Development Status of Cancer Genetics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cancer Genetics Inc

    • Figure Sales and Growth Rate Analysis of Cancer Genetics Inc

    • Figure Revenue and Market Share Analysis of Cancer Genetics Inc

    • Table Product and Service Introduction of Cancer Genetics Inc

    • Table Company Profile and Development Status of Agilent Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies

    • Figure Sales and Growth Rate Analysis of Agilent Technologies

    • Figure Revenue and Market Share Analysis of Agilent Technologies

    • Table Product and Service Introduction of Agilent Technologies

    • Table Company Profile and Development Status of Myriad Genetics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics Inc

    • Figure Sales and Growth Rate Analysis of Myriad Genetics Inc

    • Figure Revenue and Market Share Analysis of Myriad Genetics Inc

    • Table Product and Service Introduction of Myriad Genetics Inc

    • Table Company Profile and Development Status of LabCorp Of America Holdings

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LabCorp Of America Holdings

    • Figure Sales and Growth Rate Analysis of LabCorp Of America Holdings

    • Figure Revenue and Market Share Analysis of LabCorp Of America Holdings

    • Table Product and Service Introduction of LabCorp Of America Holdings

    • Table Company Profile and Development Status of Foundation Medicine Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Foundation Medicine Inc

    • Figure Sales and Growth Rate Analysis of Foundation Medicine Inc

    • Figure Revenue and Market Share Analysis of Foundation Medicine Inc

    • Table Product and Service Introduction of Foundation Medicine Inc

    • Table Company Profile and Development Status of Luminex Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Luminex Corporation

    • Figure Sales and Growth Rate Analysis of Luminex Corporation

    • Figure Revenue and Market Share Analysis of Luminex Corporation

    • Table Product and Service Introduction of Luminex Corporation


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US